Boehringer Ingelheim

Showing 15 posts of 116 posts found.

High cure rate for Boehringer HCV drug

June 11, 2013
Research and Development, Sales and Marketing Boehringer Ingelheim, HCV

One of Boehringer Ingelheim’s pipeline drugs has achieved high response rates in patients with chronic genotype-1 hepatitis C virus (HCV) in …

Boehringer unveils biopharma plant plan for China

June 6, 2013
Manufacturing and Production Boehringer Ingelheim, China

Boehringer Ingelheim has said it intends to construct a cell-culture biopharmaceutical production facility in China offering contract R&D and manufacturing …

Complications combat image

Boehringer and Lilly launch diabetes game

June 4, 2013
Medical Communications Boehringer Ingelheim, combat, lilly

Boehringer Ingelheim and Eli Lilly have launched an educational digital game for type 2 diabetes called Complications Combat. The game …

Boehringer image

Boehringer calls for ‘game changing’ ideas in health

January 29, 2013
Medical Communications, Research and Development, Sales and Marketing Ashoka Changemakers, Boehringer Ingelheim

Boehringer Ingelheim has teamed up with a social entrepreneur network to promote health projects in developing countries. This is the …

Boehringer licenses high-pressure production technology

November 20, 2012
Manufacturing and Production BaroFold, Boehringer Ingelheim

Boehringer Ingelheim has licensed a new technology from BaroFold which could improve the efficiency of biopharmaceutical production processes. Colorado, US-based …

Boehringer image

Boehringer to increase production of Respimat inhaler

October 30, 2012
Manufacturing and Production Boehringer Ingelheim, Respimat SMI, Soft Mist

Boehringer Ingelheim is investing €85 million in manufacturing capacity for its Respimat Soft Mist Inhaler in the face of growing …

engelbert_tjeenk_willink_pv

Boehringer’s Engelbert Tjeenk Willink leaves firm

September 28, 2012
Business Services, Manufacturing and Production, Medical Communications, Research and Development, Sales and Marketing Boehringer Ingelheim, Engelbert Tjeenk Willink

Boehringer Board member Engelbert Tjeenk Willink, responsible for Marketing and Sales of Prescription Medicines, has decided to leave at the …

Trajenta added to insulin recommended in Europe

September 26, 2012
Sales and Marketing Boehringer Ingelheim, Trajenta, diabetes

The CHMP has recommended that Boehringer Ingelheim and Eli Liily and Co’s diabetes brand Trajenta should be approved as add-on …

Pharma creates non-profit R&D organisation

September 21, 2012
Research and Development, Sales and Marketing Abbott, AstraZeneca, Boehringer Ingelheim, Bristol-Myers Squibb, Eli Lilly and Co, GlaxoSmithKline, Johnson & Johnson, Pfizer, R&D, Roche Genentech, Sanofi, TransCelerate BioPharma, biopharma

Ten biopharma companies have formed TransCelerate BioPharma Inc, a not-for-profit organisation using money and personnel from each firm, with a …

Amanda Paxon image

Working Life: Amanda Paxon

August 9, 2012
Business Services, Manufacturing and Production, Medical Communications, Research and Development, Sales and Marketing Amanda Paxon, Boehringer Ingelheim, Working Life

 How did you find your way into your current role? Through a combination of good luck and hard work! I …

Boehringer wins contract to make Servier’s gevokizumab

August 7, 2012
Manufacturing and Production Boehringer Ingelheim, CMO, Servier, antibody

Boehringer Ingelheim’s contract manufacturing organisation (CMO) division will provide commercial-scale manufacturing of a new monoclonal antibody developed by Servier and …

joachim_hasenmaier

Boehringer Ingelheim makes changes to board

July 5, 2012
Business Services, Manufacturing and Production, Medical Communications, Research and Development, Sales and Marketing Boehringer Ingelheim

Boehringer Ingelheim has appointed Dr Joachim Hasenmaier to its board of managing directors. The 52-year-old will take over responsibility for …

Boehringer appoints new executive director of Consumer Healthcare Marketing

May 31, 2012
Business Services, Manufacturing and Production, Medical Communications, Research and Development, Sales and Marketing Boehringer Ingelheim

Boehringer Ingelheim has announced the appointment of Ross Ullman as the executive director marketing of the Consumer Healthcare division.  In …

Boehringer Ingelheim image

A family business: Pradaxa success lifts Boehringer

April 25, 2012
Research and Development, Sales and Marketing Boehringer Ingelheim

Rapid uptake of anti-clotting drug Pradaxa in the US has helped Boehringer Ingelheim enjoy a strong year, and looks set to …

The Gateway to Local Adoption Series

Latest content